Estimation of the symptoms for GERD by GerdQ in the patients with rheumatic diseases
Objective: Gastroesophageal reflux disease (GERD) is one of the most common comorbidity in many diseases, but the frequency in rheumatic disease has not been well understood. Methods: We investigated the prevalence of GERD by GerdQ in 530 rheumatic patients [systematic lupus erythematosus (SLE; n = ...
Gespeichert in:
| Veröffentlicht in: | Modern rheumatology 2016-01, Vol.26 (2), p.265-270 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 270 |
|---|---|
| container_issue | 2 |
| container_start_page | 265 |
| container_title | Modern rheumatology |
| container_volume | 26 |
| creator | Nozaki, Yuji Kinoshita, Koji Ri, Jinhai Sakai, Kenji Shiga, Toshihiko Hino, Shoichi Hirooka, Yasuaki Sugiyama, Masahumi Funauchi, Masanori Matsumura, Itaru |
| description | Objective: Gastroesophageal reflux disease (GERD) is one of the most common comorbidity in many diseases, but the frequency in rheumatic disease has not been well understood.
Methods: We investigated the prevalence of GERD by GerdQ in 530 rheumatic patients [systematic lupus erythematosus (SLE; n = 120), rheumatoid arthritis (RA; n = 117), polymyalgia rheumatica (PMR; n = 40), dermatomyositis and polymyositis (PM/DM; n = 38), systemic scleroderma (SSc; n = 37), mixed connective tissue disease (MCTD; n = 18), Behçet disease (BD; n = 17), adult onset still disease (AOSD; n = 14), and other rheumatic diseases (n = 129)].
Results: The mean GerdQ scores of patients was 6.2 ± 1.8, respectively, and no significant differences were observed between all patients. However, the GERD prevalence in SSc and BD was increased compared to that in SLE, RA, PMR, PM/DM, MCTD, and AOSD. In no medication of proton pump inhibitors (PPIs), a significant increase in the risk of GERD symptoms was 2.5 times compared with that in the medication of PPIs in all patients by multivariable regression analysis. On the other hand, there were no increased risks of GERD symptoms with corticosteroids.
Conclusion: In rheumatic diseases, GerdQ would be the useful tool of diagnosis GERD, regardless whether the patients complain or not about gastrointestinal (GI) symptoms. |
| doi_str_mv | 10.3109/14397595.2015.1077556 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_3109_14397595_2015_1077556</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4069961481</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-765113c2a35d0be454e27d96cade0d934e476cc319ba53aa69727c517f1465073</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlZ_ghLw4qU12Xw1N6XWKhREqeeQZrN0y-6mJllK_71Z23rw4GmG4Zl3hgeAa4xGBCN5jymRgkk2yhBmI4yEYIyfgH43HwqO5OmxT1APXISwRogwOZbnoJdxwhHPaB8spiGWtY6la6ArYFxZGHb1Jro6wMJ5OJt-PMHlDs6sz99h2fwQm8TbJga4LeMK-pVtuwQD8zJYHWy4BGeFroK9OtQB-HyeLiYvw_nb7HXyOB8aSnhMXzKMick0YTlaWsqozUQuudG5Rbkk1FLBjSFYLjUjWnMpMmEYFgWmnCFBBuBun7vx7qu1Iaq6DMZWlW6sa4PCgo8ZR2NCE3r7B1271jfpu0RJLAUeM5wotqeMdyF4W6iNT3b8TmGkOu3qqF112tVBe9q7OaS3y9rmv1tHzwl42ANlk6zWeut8lauod5XzhdeNKUOX_9-Nb_osj5k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1791971851</pqid></control><display><type>article</type><title>Estimation of the symptoms for GERD by GerdQ in the patients with rheumatic diseases</title><source>MEDLINE</source><source>Oxford University Press</source><creator>Nozaki, Yuji ; Kinoshita, Koji ; Ri, Jinhai ; Sakai, Kenji ; Shiga, Toshihiko ; Hino, Shoichi ; Hirooka, Yasuaki ; Sugiyama, Masahumi ; Funauchi, Masanori ; Matsumura, Itaru</creator><creatorcontrib>Nozaki, Yuji ; Kinoshita, Koji ; Ri, Jinhai ; Sakai, Kenji ; Shiga, Toshihiko ; Hino, Shoichi ; Hirooka, Yasuaki ; Sugiyama, Masahumi ; Funauchi, Masanori ; Matsumura, Itaru</creatorcontrib><description>Objective: Gastroesophageal reflux disease (GERD) is one of the most common comorbidity in many diseases, but the frequency in rheumatic disease has not been well understood.
Methods: We investigated the prevalence of GERD by GerdQ in 530 rheumatic patients [systematic lupus erythematosus (SLE; n = 120), rheumatoid arthritis (RA; n = 117), polymyalgia rheumatica (PMR; n = 40), dermatomyositis and polymyositis (PM/DM; n = 38), systemic scleroderma (SSc; n = 37), mixed connective tissue disease (MCTD; n = 18), Behçet disease (BD; n = 17), adult onset still disease (AOSD; n = 14), and other rheumatic diseases (n = 129)].
Results: The mean GerdQ scores of patients was 6.2 ± 1.8, respectively, and no significant differences were observed between all patients. However, the GERD prevalence in SSc and BD was increased compared to that in SLE, RA, PMR, PM/DM, MCTD, and AOSD. In no medication of proton pump inhibitors (PPIs), a significant increase in the risk of GERD symptoms was 2.5 times compared with that in the medication of PPIs in all patients by multivariable regression analysis. On the other hand, there were no increased risks of GERD symptoms with corticosteroids.
Conclusion: In rheumatic diseases, GerdQ would be the useful tool of diagnosis GERD, regardless whether the patients complain or not about gastrointestinal (GI) symptoms.</description><identifier>ISSN: 1439-7595</identifier><identifier>EISSN: 1439-7609</identifier><identifier>DOI: 10.3109/14397595.2015.1077556</identifier><identifier>PMID: 26360624</identifier><language>eng</language><publisher>United States: Taylor & Francis</publisher><subject>Adult ; Aged ; Comorbidity ; Female ; Gastroesophageal reflux ; Gastroesophageal Reflux - diagnosis ; Gastroesophageal Reflux - epidemiology ; Gastroesophageal reflux disease ; Humans ; Male ; Middle Aged ; Prevalence ; Regression analysis ; Rheumatic disease ; Rheumatic Diseases - epidemiology ; Rheumatoid arthritis ; Rheumatology ; Risk assessment ; Symptom Assessment</subject><ispartof>Modern rheumatology, 2016-01, Vol.26 (2), p.265-270</ispartof><rights>2015 Japan College of Rheumatology 2015</rights><rights>Copyright Informa Healthcare 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c436t-765113c2a35d0be454e27d96cade0d934e476cc319ba53aa69727c517f1465073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26360624$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nozaki, Yuji</creatorcontrib><creatorcontrib>Kinoshita, Koji</creatorcontrib><creatorcontrib>Ri, Jinhai</creatorcontrib><creatorcontrib>Sakai, Kenji</creatorcontrib><creatorcontrib>Shiga, Toshihiko</creatorcontrib><creatorcontrib>Hino, Shoichi</creatorcontrib><creatorcontrib>Hirooka, Yasuaki</creatorcontrib><creatorcontrib>Sugiyama, Masahumi</creatorcontrib><creatorcontrib>Funauchi, Masanori</creatorcontrib><creatorcontrib>Matsumura, Itaru</creatorcontrib><title>Estimation of the symptoms for GERD by GerdQ in the patients with rheumatic diseases</title><title>Modern rheumatology</title><addtitle>Mod Rheumatol</addtitle><description>Objective: Gastroesophageal reflux disease (GERD) is one of the most common comorbidity in many diseases, but the frequency in rheumatic disease has not been well understood.
Methods: We investigated the prevalence of GERD by GerdQ in 530 rheumatic patients [systematic lupus erythematosus (SLE; n = 120), rheumatoid arthritis (RA; n = 117), polymyalgia rheumatica (PMR; n = 40), dermatomyositis and polymyositis (PM/DM; n = 38), systemic scleroderma (SSc; n = 37), mixed connective tissue disease (MCTD; n = 18), Behçet disease (BD; n = 17), adult onset still disease (AOSD; n = 14), and other rheumatic diseases (n = 129)].
Results: The mean GerdQ scores of patients was 6.2 ± 1.8, respectively, and no significant differences were observed between all patients. However, the GERD prevalence in SSc and BD was increased compared to that in SLE, RA, PMR, PM/DM, MCTD, and AOSD. In no medication of proton pump inhibitors (PPIs), a significant increase in the risk of GERD symptoms was 2.5 times compared with that in the medication of PPIs in all patients by multivariable regression analysis. On the other hand, there were no increased risks of GERD symptoms with corticosteroids.
Conclusion: In rheumatic diseases, GerdQ would be the useful tool of diagnosis GERD, regardless whether the patients complain or not about gastrointestinal (GI) symptoms.</description><subject>Adult</subject><subject>Aged</subject><subject>Comorbidity</subject><subject>Female</subject><subject>Gastroesophageal reflux</subject><subject>Gastroesophageal Reflux - diagnosis</subject><subject>Gastroesophageal Reflux - epidemiology</subject><subject>Gastroesophageal reflux disease</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prevalence</subject><subject>Regression analysis</subject><subject>Rheumatic disease</subject><subject>Rheumatic Diseases - epidemiology</subject><subject>Rheumatoid arthritis</subject><subject>Rheumatology</subject><subject>Risk assessment</subject><subject>Symptom Assessment</subject><issn>1439-7595</issn><issn>1439-7609</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotlZ_ghLw4qU12Xw1N6XWKhREqeeQZrN0y-6mJllK_71Z23rw4GmG4Zl3hgeAa4xGBCN5jymRgkk2yhBmI4yEYIyfgH43HwqO5OmxT1APXISwRogwOZbnoJdxwhHPaB8spiGWtY6la6ArYFxZGHb1Jro6wMJ5OJt-PMHlDs6sz99h2fwQm8TbJga4LeMK-pVtuwQD8zJYHWy4BGeFroK9OtQB-HyeLiYvw_nb7HXyOB8aSnhMXzKMick0YTlaWsqozUQuudG5Rbkk1FLBjSFYLjUjWnMpMmEYFgWmnCFBBuBun7vx7qu1Iaq6DMZWlW6sa4PCgo8ZR2NCE3r7B1271jfpu0RJLAUeM5wotqeMdyF4W6iNT3b8TmGkOu3qqF112tVBe9q7OaS3y9rmv1tHzwl42ANlk6zWeut8lauod5XzhdeNKUOX_9-Nb_osj5k</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Nozaki, Yuji</creator><creator>Kinoshita, Koji</creator><creator>Ri, Jinhai</creator><creator>Sakai, Kenji</creator><creator>Shiga, Toshihiko</creator><creator>Hino, Shoichi</creator><creator>Hirooka, Yasuaki</creator><creator>Sugiyama, Masahumi</creator><creator>Funauchi, Masanori</creator><creator>Matsumura, Itaru</creator><general>Taylor & Francis</general><general>Informa Healthcare</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20160101</creationdate><title>Estimation of the symptoms for GERD by GerdQ in the patients with rheumatic diseases</title><author>Nozaki, Yuji ; Kinoshita, Koji ; Ri, Jinhai ; Sakai, Kenji ; Shiga, Toshihiko ; Hino, Shoichi ; Hirooka, Yasuaki ; Sugiyama, Masahumi ; Funauchi, Masanori ; Matsumura, Itaru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-765113c2a35d0be454e27d96cade0d934e476cc319ba53aa69727c517f1465073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Comorbidity</topic><topic>Female</topic><topic>Gastroesophageal reflux</topic><topic>Gastroesophageal Reflux - diagnosis</topic><topic>Gastroesophageal Reflux - epidemiology</topic><topic>Gastroesophageal reflux disease</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prevalence</topic><topic>Regression analysis</topic><topic>Rheumatic disease</topic><topic>Rheumatic Diseases - epidemiology</topic><topic>Rheumatoid arthritis</topic><topic>Rheumatology</topic><topic>Risk assessment</topic><topic>Symptom Assessment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nozaki, Yuji</creatorcontrib><creatorcontrib>Kinoshita, Koji</creatorcontrib><creatorcontrib>Ri, Jinhai</creatorcontrib><creatorcontrib>Sakai, Kenji</creatorcontrib><creatorcontrib>Shiga, Toshihiko</creatorcontrib><creatorcontrib>Hino, Shoichi</creatorcontrib><creatorcontrib>Hirooka, Yasuaki</creatorcontrib><creatorcontrib>Sugiyama, Masahumi</creatorcontrib><creatorcontrib>Funauchi, Masanori</creatorcontrib><creatorcontrib>Matsumura, Itaru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Modern rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nozaki, Yuji</au><au>Kinoshita, Koji</au><au>Ri, Jinhai</au><au>Sakai, Kenji</au><au>Shiga, Toshihiko</au><au>Hino, Shoichi</au><au>Hirooka, Yasuaki</au><au>Sugiyama, Masahumi</au><au>Funauchi, Masanori</au><au>Matsumura, Itaru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Estimation of the symptoms for GERD by GerdQ in the patients with rheumatic diseases</atitle><jtitle>Modern rheumatology</jtitle><addtitle>Mod Rheumatol</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>26</volume><issue>2</issue><spage>265</spage><epage>270</epage><pages>265-270</pages><issn>1439-7595</issn><eissn>1439-7609</eissn><abstract>Objective: Gastroesophageal reflux disease (GERD) is one of the most common comorbidity in many diseases, but the frequency in rheumatic disease has not been well understood.
Methods: We investigated the prevalence of GERD by GerdQ in 530 rheumatic patients [systematic lupus erythematosus (SLE; n = 120), rheumatoid arthritis (RA; n = 117), polymyalgia rheumatica (PMR; n = 40), dermatomyositis and polymyositis (PM/DM; n = 38), systemic scleroderma (SSc; n = 37), mixed connective tissue disease (MCTD; n = 18), Behçet disease (BD; n = 17), adult onset still disease (AOSD; n = 14), and other rheumatic diseases (n = 129)].
Results: The mean GerdQ scores of patients was 6.2 ± 1.8, respectively, and no significant differences were observed between all patients. However, the GERD prevalence in SSc and BD was increased compared to that in SLE, RA, PMR, PM/DM, MCTD, and AOSD. In no medication of proton pump inhibitors (PPIs), a significant increase in the risk of GERD symptoms was 2.5 times compared with that in the medication of PPIs in all patients by multivariable regression analysis. On the other hand, there were no increased risks of GERD symptoms with corticosteroids.
Conclusion: In rheumatic diseases, GerdQ would be the useful tool of diagnosis GERD, regardless whether the patients complain or not about gastrointestinal (GI) symptoms.</abstract><cop>United States</cop><pub>Taylor & Francis</pub><pmid>26360624</pmid><doi>10.3109/14397595.2015.1077556</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1439-7595 |
| ispartof | Modern rheumatology, 2016-01, Vol.26 (2), p.265-270 |
| issn | 1439-7595 1439-7609 |
| language | eng |
| recordid | cdi_crossref_primary_10_3109_14397595_2015_1077556 |
| source | MEDLINE; Oxford University Press |
| subjects | Adult Aged Comorbidity Female Gastroesophageal reflux Gastroesophageal Reflux - diagnosis Gastroesophageal Reflux - epidemiology Gastroesophageal reflux disease Humans Male Middle Aged Prevalence Regression analysis Rheumatic disease Rheumatic Diseases - epidemiology Rheumatoid arthritis Rheumatology Risk assessment Symptom Assessment |
| title | Estimation of the symptoms for GERD by GerdQ in the patients with rheumatic diseases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T19%3A31%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Estimation%20of%20the%20symptoms%20for%20GERD%20by%20GerdQ%20in%20the%20patients%20with%20rheumatic%20diseases&rft.jtitle=Modern%20rheumatology&rft.au=Nozaki,%20Yuji&rft.date=2016-01-01&rft.volume=26&rft.issue=2&rft.spage=265&rft.epage=270&rft.pages=265-270&rft.issn=1439-7595&rft.eissn=1439-7609&rft_id=info:doi/10.3109/14397595.2015.1077556&rft_dat=%3Cproquest_cross%3E4069961481%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1791971851&rft_id=info:pmid/26360624&rfr_iscdi=true |